
Building better breakpoints: data and methods needed to determine breakpoints for new agents
more
Exploring safety issues in antimicrobial drug development
more
Moving from preclinical to clinical-stage: Challenges & opportunities
more
The challenges and opportunities for antimicrobial R&D in low- and middle-income countries – India case study
more
Test tube to patient: PK/PD of fixed dose beta-lactam/beta-lactamase inhibitor combinations
more
Probability of target attainment analyses for dose selection in antimicrobial drug development
more
Inhaled antimicrobials: Do we get the drug to the bug?
more
PK/PD murine infection models: Focus on study elements, variability, and interpretation of results
more